1. Home
  2. M vs TFX Comparison

M vs TFX Comparison

Compare M & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Macy's Inc

M

Macy's Inc

HOLD

Current Price

$19.59

Market Cap

5.2B

ML Signal

HOLD

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$120.33

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
M
TFX
Founded
1830
1943
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.6B
IPO Year
2002
1994

Fundamental Metrics

Financial Performance
Metric
M
TFX
Price
$19.59
$120.33
Analyst Decision
Hold
Buy
Analyst Count
13
8
Target Price
$20.09
$138.75
AVG Volume (30 Days)
4.3M
894.3K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
3.97%
1.02%
EPS Growth
12.08
N/A
EPS
2.32
N/A
Revenue
$22,621,000,000.00
$1,992,713,000.00
Revenue This Year
N/A
$15.97
Revenue Next Year
N/A
$5.15
P/E Ratio
$8.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.99
$100.18
52 Week High
$24.41
$139.67

Technical Indicators

Market Signals
Indicator
M
TFX
Relative Strength Index (RSI) 53.22 43.94
Support Level $19.00 $117.09
Resistance Level $20.95 $126.13
Average True Range (ATR) 0.55 4.75
MACD -0.02 -1.71
Stochastic Oscillator 34.38 0.41

Price Performance

Historical Comparison
M
TFX

About M Macy's Inc

Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Share on Social Networks: